0720 Rivus series A EMB Tue 7a ET
BioCentury & Getty Images

Emerging Company Profile

Rivus debuts to find safer way to tap mitochondria for metabolic, CV disorders

Emerging Company Profile: Longitude, Medicxi-backed company looks to mitochondrial uncoupling for NASH, diabetes and more

The Longitude, Medicxi-backed company is looking to mitochondrial uncoupling for NASH, diabetes and more. 

Jul 20, 2021 | 11:02 AM GMT

With

Read the full 605 word article

How to gain access

Continue reading with a
two-week free trial.